Cidara Therapeutics, Inc. (CDTX)

NASDAQ: CDTX · Real-Time Price · USD

220.36

-0.14 (-0.06%)

At close: Dec 5, 2025, 4:00 PM EST

219.64

-0.72 (-0.33%)

After-hours: Dec 5, 2025, 7:16 PM EST

Cidara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	6,928	294	72	54	85	88	Upgrade
Market Cap Growth	6192.44%	309.50%	32.57%	-36.04%	-3.62%	-30.74%	Upgrade
Enterprise Value	6,510	171	27	3	54	52	Upgrade
Last Close Price	220.36	26.88	15.88	15.13	25.40	40.00	Upgrade
PS Ratio	-	230.62	3.08	2.31	1.71	7.28	Upgrade
PB Ratio	15.30	1.80	-8.75	-3.75	3.93	8.20	Upgrade
P/TBV Ratio	16.40	1.80	-	-	3.93	8.20	Upgrade
EV/Sales Ratio	-	133.80	1.18	0.12	1.10	4.28	Upgrade
Debt / Equity Ratio	0.01	0.02	-0.59	-0.08	0.24	0.74	Upgrade
Asset Turnover	-	0.01	0.41	0.38	0.73	0.19	Upgrade
Quick Ratio	4.40	3.87	0.74	0.93	1.91	1.22	Upgrade
Current Ratio	4.62	4.25	0.90	1.09	2.11	1.48	Upgrade
Return on Equity (ROE)	-68.70%	-219.59%	-	-608.89%	-263.05%	-297.06%	Upgrade
Return on Assets (ROA)	-29.35%	-40.46%	-29.54%	-22.29%	-38.91%	-69.41%	Upgrade
Return on Capital (ROIC)	-36.75%	-69.72%	-	-204.17%	-116.57%	-131.62%	Upgrade
Return on Capital Employed (ROCE)	-37.80%	-55.20%	6974.20%	-359.80%	-102.30%	-328.70%	Upgrade
Earnings Yield	-2.67%	-57.76%	-31.94%	-62.00%	-50.14%	-82.06%	Upgrade
FCF Yield	-1.92%	-60.08%	-31.94%	-52.79%	-29.84%	-62.13%	Upgrade
Buyback Yield / Dilution	-229.65%	-45.26%	-25.15%	-33.18%	-26.22%	-38.83%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q